Skip to main content


Media Coverage

Court sides with investors on disclosing drug reactions

23 March 2011
USA Today
Chicago Litigation partner Josh Yount quoted on a Supreme Court ruling that drug companies must disclose adverse reports if they could affect the company’s share price.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.